Team reports on synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells

Team reports on synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells retrieved 5 June 2024 from https://medicalxpress.com/news/2024-06-team-synergistic-cytotoxicity-hdac-parp.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brainUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers identify what drives PARP inhibitor resistance in advanced breast cancerResearchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who's more likely to respond to these drugs, and could lead to more effective ways to treat the disease.
Source: medical_xpress - 🏆 101. / 51 Read more »